More importantly, our data showed that CPEB4 overexpression alone appeared to be an independent prognostic factor for OS in glioma patients, which suggests that the detection of CPEB4 may be valuable for the design of optimal individualized treatments and for the identification of patients who may or may not benefit from close monitoring after surgery. The gene discussed is CPEB4; the disease is central nervous system cancer.